tiprankstipranks
Trending News
More News >
C21 Investments (TSE:CXXI)
:CXXI
Advertisement

C21 Investments (CXXI) AI Stock Analysis

Compare
9 Followers

Top Page

TSE:CXXI

C21 Investments

(OTC:CXXI)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 4o)
Rating:49Neutral
Price Target:
C$0.50
▼(-12.28% Downside)
C21 Investments' overall stock score is primarily influenced by its mixed financial performance and valuation challenges. While there are some positive technical indicators, the negative P/E ratio and lack of dividend yield weigh heavily on the score.

C21 Investments (CXXI) vs. iShares MSCI Canada ETF (EWC)

C21 Investments Business Overview & Revenue Model

Company DescriptionC21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. It offers packaged and wholesale flower, vaporizer pens, cured extracts, edibles, pre-rolls, tinctures, and topicals; and payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in November 2017. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada.
How the Company Makes MoneyC21 Investments generates revenue primarily through the sale of cannabis products from its dispensaries and cultivation facilities. The company operates retail outlets that sell a variety of cannabis goods, which represent a significant portion of its revenue. Additionally, C21 Investments earns money from wholesale distribution to other dispensaries and businesses in the cannabis supply chain. Key revenue streams include direct sales from retail locations, wholesale transactions, and potentially licensing agreements that allow other businesses to sell C21 products. The company may also benefit from strategic partnerships with suppliers, distributors, and other players in the cannabis industry, which can enhance its market reach and operational efficiency.

C21 Investments Financial Statement Overview

Summary
C21 Investments faces financial challenges with declining revenues, inconsistent profitability, and cash flow issues. Despite a balanced leverage position, the declining asset base and equity raise concerns about financial stability.
Income Statement
45
Neutral
C21 Investments has experienced declining revenues over the past few years, with total revenue dropping from $37.7M in 2020 to $30.1M in 2025. The company has also faced challenges in maintaining profitability, as evidenced by a negative net income in recent years and a declining gross profit margin from 2022 to 2025. While there are periods of increased gross profit, such as in 2020, the overall trend shows financial instability.
Balance Sheet
50
Neutral
The balance sheet of C21 Investments shows a moderate Debt-to-Equity ratio, indicating a balanced leverage position. However, the declining equity and increasing liabilities over time present potential risks. The company's total assets have decreased from $68.8M in 2021 to $57M in 2025, reflecting a contraction in asset base. Despite these challenges, the company has managed to maintain a positive equity ratio, suggesting some stability.
Cash Flow
40
Negative
C21 Investments has experienced fluctuations in free cash flow, with significant negative values in 2025. The operating cash flow has been positive but inconsistent, which, coupled with negative free cash flow growth, indicates cash management challenges. While there were periods of positive free cash flow, the inability to sustain this trend raises concerns about the company's cash-generating ability.
BreakdownTTMDec 2025Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue32.08M30.12M28.29M28.89M32.98M33.47M
Gross Profit13.51M12.56M11.15M13.40M18.81M18.05M
EBITDA4.57M2.90M2.63M6.98M20.72M5.79M
Net Income-3.32M-3.97M-3.31M293.21K9.96M-7.83M
Balance Sheet
Total Assets56.40M57.00M54.53M58.31M61.85M68.81M
Cash, Cash Equivalents and Short-Term Investments2.66M2.63M2.41M1.89M3.07M6.24M
Total Debt12.88M13.15M10.72M12.14M18.67M27.30M
Total Liabilities28.50M28.32M23.48M24.00M26.87M43.47M
Stockholders Equity27.90M28.68M31.05M34.32M34.98M25.34M
Cash Flow
Free Cash Flow844.24K-2.63M5.46M5.46M4.27M9.70M
Operating Cash Flow1.12M1.19M5.90M5.90M6.84M9.92M
Investing Cash Flow423.26K-3.12M-390.93K-390.93K-1.39M-1.10M
Financing Cash Flow-2.02M1.27M-6.68M-6.68M-7.84M-5.70M

C21 Investments Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.57
Price Trends
50DMA
0.52
Positive
100DMA
0.41
Positive
200DMA
0.32
Positive
Market Momentum
MACD
<0.01
Positive
RSI
50.03
Neutral
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CXXI, the sentiment is Positive. The current price of 0.57 is above the 20-day moving average (MA) of 0.56, above the 50-day MA of 0.52, and above the 200-day MA of 0.32, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 50.03 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CXXI.

C21 Investments Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
C$53.57M30.746.23%34.71%
C$69.32M-20.91%36.50%-306.47%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
$36.95M203.700.61%34.19%
C$63.60M-10.63%21.71%18.75%
$31.81M-109.32%2.00%80.83%
C$22.48M-15.75%26.75%61.79%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:CXXI
C21 Investments
0.54
0.25
86.21%
TSE:EPIC
1CM Inc
0.46
0.21
82.00%
TSE:ROMJ
Rubicon Organics
0.47
0.08
20.78%
TSE:VEXT
Vext Science
0.28
0.09
47.37%
TSE:AVCN
Avicanna
0.27
-0.01
-3.57%
TSE:GWAY
Greenway Greenhouse Cannabis Corp.
0.17
-0.25
-59.52%

C21 Investments Corporate Events

C21 Investments Issues New Shares to Maintain Foreign Private Issuer Status
Sep 9, 2025

On September 8, 2025, C21 Investments Inc. announced the issuance of 100,000,000 Subordinate Voting Shares at a nominal price to maintain its status as a ‘foreign private issuer’ under U.S. securities law. This move is intended to reduce compliance costs and does not result in a change of control for the company.

The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.

Business Operations and StrategyRegulatory Filings and Compliance
C21 Investments Completes Strategic Share Structure Adjustment
Neutral
Sep 8, 2025

C21 Investments Inc. has completed a transaction to create and issue a new class of subordinate voting shares, designed to maintain its status as a foreign private issuer in the United States and reduce compliance costs. This move is strategic for the company as it ensures no impact on the economic or voting rights of existing common shareholders, while providing flexibility in share structure and maintaining regulatory compliance.

The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.

Business Operations and StrategyLegal Proceedings
C21 Investments Settles Eco Firma Farms Litigation, Stabilizes Financial Position
Positive
Sep 5, 2025

C21 Investments Inc. has reached a settlement agreement regarding litigation involving its subsidiary Eco Firma Farms, resolving disputes with Proudest Monkey Holdings and its owners. The settlement, which includes a cash payment of $2.4 million and issuance of company shares, will dismiss all claims and offset certain financial liabilities, potentially stabilizing C21’s financial position and allowing it to focus on its core business operations.

The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.

C21 Investments Announces September 2025 Shareholder Meeting
Aug 25, 2025

C21 Investments Inc. has announced its upcoming Annual General Meeting of shareholders, scheduled for September 23, 2025, in Vancouver, British Columbia. The meeting will address several key issues, including the presentation of audited financial statements for the year ending March 31, 2025, the election of four directors, and the appointment of an auditor for the upcoming year. Shareholders of record as of July 30, 2025, are eligible to vote, and those unable to attend in person are encouraged to submit their proxies by September 19, 2025. This meeting is crucial for stakeholders as it will shape the company’s governance and financial oversight for the coming year.

The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.

C21 Investments Announces Amendment for September 2025 Meeting
Aug 14, 2025

C21 Investments Inc. has announced an amendment regarding its upcoming Annual and Special Meeting of Security Holders, scheduled for September 23, 2025, in Vancouver, BC. The meeting will address matters pertinent to the company’s stakeholders, with record dates for notice and voting set for July 30, 2025. This announcement is significant as it outlines the procedural details for the meeting, which could impact shareholder decisions and the company’s strategic direction.

C21 Investments Announces Amended Notice for September AGM
Aug 8, 2025

C21 Investments Inc. announced an amended notice for its upcoming Annual General Meeting of Security Holders, scheduled for September 23, 2025, in Vancouver, BC. The record date for notice and voting was set for July 30, 2025. This announcement is significant for stakeholders as it outlines the procedural details of the meeting, which is crucial for shareholder engagement and governance.

Business Operations and StrategyFinancial Disclosures
C21 Investments Achieves 30% Revenue Growth in Q1 2025
Positive
Jul 31, 2025

C21 Investments reported a 30% year-over-year revenue growth for the first quarter of 2025, reaching $8.6 million, despite a decline in Nevada state sales. The growth was driven by same-store sales and increased wholesale volume. The company achieved a gross margin of 35% and reported a net income before tax of $0.1 million, although it faced a net loss primarily due to income tax provisions. C21’s operational efficiency and retail strategy have been highlighted as key factors in its robust performance, with significant growth in retail transactions and a focus on long-term sustainable growth.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025